2 dividend growth shares I’d buy to boost the passive income from my ISA

I think these FTSE 100 and FTSE 250 dividend shares could prove a great way to grow my wealth. Give me a few minutes to explain why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian man drinking coffee at home and looking at his phone

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m looking for the best dividend shares to help me build a growing passive income. Here are two I’m hoping to add to my Stocks and Shares ISA in the coming weeks.

Spire Healthcare

Private hospital operator Spire Healthcare (LSE:SPI) is thriving as NHS waiting lists remain cripplingly high. Most recent financials showed revenues soar 13.1% and operating profit increase 24.2% during the first half of 2023.

Demand for private healthcare is surging in the UK as people turn to medical insurance and pay for their own treatments. Furthermore, revenues are increasing as these businesses step in to help reduce the NHS backlog. NHS-related turnover at Spire rose by almost a fifth between January and June.

Latest data showed there were 7.6m Britons on NHS waiting lists as of February. This will take years to decline given the state of the UK’s public finances which, in turn, provides private healthcare groups like this with excellent earnings visibility.

One fly in the ointment is the prospect that high labour costs could keep a lid on Spire’s margins. But encouragingly the company is enacting efficiency measures (like improving procurement and reorganising its hospitals into hubs) to offset these pressures.

City analysts expect the FTSE 250 company’s dividends to surge 40% year on year in 2024. While this results in a modest 1.2% dividend yield, the prospect of strong and sustained payout growth makes it a top stock to buy, in my opinion.

It’s why I already own Spire Healthcare shares in my ISA.


I’m also hoping to open a position in Halma (LSE:HLMA) at the next opportunity. The safety products manufacturer is a true Dividend Aristocrat, having raised the annual payout by at least 5% for 44 straight years.

And City brokers expect this proud record to carry on. Dividend growth of 7% and 9% is forecast for the financial years to March 2024 and 2025 respectively. Consequently, Halma shares carry yields of 1.1% and 1.2% for these fiscal periods.

As well as being a brilliant dividend growth stock, the business is also one of the FTSE 100‘s greatest growth shares. It has delivered record sales and profits for 20 consecutive years.

This is thanks to its outstanding ability of identifying takeover targets, seamlessly integrating them into the wider group, and supercharging their efficiency. Acquisitions can throw up unexpected problems like disappointing sales and higher-than-expected costs. But Halma’s strong track record is encouraging.

Today, Halma owns a portfolio of around 50 companies located in 20 different countries. This is an attractive quality as it provides profits with extra stability. In other words, trouble for one or two businesses doesn’t derail results at group level.

I also like the company because its focus on safety, healthcare and the environment provides opportunities for excellent long term growth. This is thanks to phenomena like increasing regulation, rising healthcare demand, and the fight against climate change.

Like Spire, I’ll be looking to buy Halma shares when I next have cash to invest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has recommended Halma Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »